Skip to main content
Erschienen in: International Ophthalmology 4/2018

27.07.2017 | Original Paper

Neuro-ophthalmological findings in TAFRO syndrome in a patient from South America, a variant of multicentric Castleman’s disease

verfasst von: Alvaro Ortiz, Pedro Cárdenas, Marcela Peralta, Harold Rodríguez, Gabriel Frederick, Jacobo Ortiz

Erschienen in: International Ophthalmology | Ausgabe 4/2018

Einloggen, um Zugang zu erhalten

Abstract

Background

To report the neuro-ophthalmological findings in the TAFRO syndrome in a South American patient.

Methods

This is a case report of a patient with TAFRO syndrome.

Results

We present the case of a 66-year-old woman with TAFRO syndrome and multicentric Castleman disease, who developed ophthalmic manifestations, as a rare complication, including optic disk edema and serous retinal detachment, which improved with conventional therapy.

Conclusions

The optic disk edema could be present as a neuro-ophthalmological finding in TAFRO syndrome. To the best of our knowledge, this is the first report on the ophthalmic manifestations in the TAFRO syndrome.
Literatur
1.
Zurück zum Zitat Takai K, Nikkuni K, Shibuya H, Hashidate H (2010) Thrombocytopenia with mild bone marrow fibrosis accompanied by fever, pleural effusion, ascites and hepatosplenomegaly. Rinsho Ketsueki 51(5):320–325PubMed Takai K, Nikkuni K, Shibuya H, Hashidate H (2010) Thrombocytopenia with mild bone marrow fibrosis accompanied by fever, pleural effusion, ascites and hepatosplenomegaly. Rinsho Ketsueki 51(5):320–325PubMed
2.
Zurück zum Zitat Masaki Y, Kawabata H, Takai K, Kojima M, Tsukamoto N, Ishigaki Y et al (2016) Proposed diagnostic criteria, disease severity classification and treatment strategy for TAFRO syndrome, 2015 version. Int J Hematol 103(6):686–692CrossRefPubMed Masaki Y, Kawabata H, Takai K, Kojima M, Tsukamoto N, Ishigaki Y et al (2016) Proposed diagnostic criteria, disease severity classification and treatment strategy for TAFRO syndrome, 2015 version. Int J Hematol 103(6):686–692CrossRefPubMed
3.
Zurück zum Zitat Yasuda S, Tanaka K, Ichikawa A, Watanabe K, Uchida E, Yamamoto M et al (2016) Aggressive TAFRO syndrome with reversible cardiomyopathy successfully treated with combination chemotherapy. Int J Hematol 104(4):512–518CrossRefPubMed Yasuda S, Tanaka K, Ichikawa A, Watanabe K, Uchida E, Yamamoto M et al (2016) Aggressive TAFRO syndrome with reversible cardiomyopathy successfully treated with combination chemotherapy. Int J Hematol 104(4):512–518CrossRefPubMed
4.
Zurück zum Zitat Simons M, Apor E, Butera JN, Treaba DO (2016) TAFRO syndrome associated with EBV and successful triple therapy treatment: case report and review of the literature. Case Rep Hematol 2016:4703608PubMedPubMedCentral Simons M, Apor E, Butera JN, Treaba DO (2016) TAFRO syndrome associated with EBV and successful triple therapy treatment: case report and review of the literature. Case Rep Hematol 2016:4703608PubMedPubMedCentral
5.
Zurück zum Zitat Kawabata H, Takai K, Kojima M, Nakamura N, Aoki S, Nakamura S et al (2013) Castleman-Kojima disease (TAFRO syndrome): a novel systemic inflammatory disease characterized by a constellation of symptoms, namely, thrombocytopenia, ascites (anasarca), microcytic anemia, myelofibrosis, renal dysfunction, and organomegaly: a status report and summary of Fukushima (6 June, 2012) and Nagoya meetings (22 September, 2012). J Clin Exp Hematop 53(1):57–61CrossRefPubMed Kawabata H, Takai K, Kojima M, Nakamura N, Aoki S, Nakamura S et al (2013) Castleman-Kojima disease (TAFRO syndrome): a novel systemic inflammatory disease characterized by a constellation of symptoms, namely, thrombocytopenia, ascites (anasarca), microcytic anemia, myelofibrosis, renal dysfunction, and organomegaly: a status report and summary of Fukushima (6 June, 2012) and Nagoya meetings (22 September, 2012). J Clin Exp Hematop 53(1):57–61CrossRefPubMed
6.
Zurück zum Zitat Tedesco S, Postacchini L, Manfredi L, Goteri G, Luchetti MM, Festa A et al (2015) Successful treatment of a Caucasian case of multifocal Castleman’s disease with TAFRO syndrome with a pathophysiology targeted therapy - a case report. Exp Hematol Oncol 4(1):3CrossRefPubMedPubMedCentral Tedesco S, Postacchini L, Manfredi L, Goteri G, Luchetti MM, Festa A et al (2015) Successful treatment of a Caucasian case of multifocal Castleman’s disease with TAFRO syndrome with a pathophysiology targeted therapy - a case report. Exp Hematol Oncol 4(1):3CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Abdo LA, Morin CP, Collarino RP, Cabane JP, Gatfosse MA (2014) First European case of TAFRO syndrome associated with Sjogren disease. Am J Intern Med 2(6):102–105 Abdo LA, Morin CP, Collarino RP, Cabane JP, Gatfosse MA (2014) First European case of TAFRO syndrome associated with Sjogren disease. Am J Intern Med 2(6):102–105
9.
Zurück zum Zitat Castleman B, Iverson L, Menendez VP (1956) Localized mediastinal lymph node hyperplasia resembling thymoma. Cancer 9(4):822–830CrossRefPubMed Castleman B, Iverson L, Menendez VP (1956) Localized mediastinal lymph node hyperplasia resembling thymoma. Cancer 9(4):822–830CrossRefPubMed
10.
Zurück zum Zitat Allegra A, Rotondo F, Russo S, Calabrò L, Maisano V, Bacci F et al (2015) Castleman-Kojima disease (TAFRO syndrome) in a Caucasian patient: a rare case report and review of the literature. Blood Cells Mol Dis 55(3):206–207CrossRefPubMed Allegra A, Rotondo F, Russo S, Calabrò L, Maisano V, Bacci F et al (2015) Castleman-Kojima disease (TAFRO syndrome) in a Caucasian patient: a rare case report and review of the literature. Blood Cells Mol Dis 55(3):206–207CrossRefPubMed
11.
Zurück zum Zitat Takasawa N, Sekiguchi Y, Takahashi T, Muryoi A, Satoh J, Sasaki T (2016) A case of TAFRO syndrome, a variant of multicentric Castleman’s disease, successfully treated with corticosteroid and cyclosporine A. Mod Rheumatol 14:1–5CrossRef Takasawa N, Sekiguchi Y, Takahashi T, Muryoi A, Satoh J, Sasaki T (2016) A case of TAFRO syndrome, a variant of multicentric Castleman’s disease, successfully treated with corticosteroid and cyclosporine A. Mod Rheumatol 14:1–5CrossRef
12.
Zurück zum Zitat Iwaki N, Fajgenbaum DC, Nabel CS, Gion Y, Kondo E, Kawano M et al (2016) Clinicopathologic analysis of TAFRO syndrome demonstrates a distinct subtype of HHV-8-negative multicentric Castleman disease. Am J Hematol 91(2):220–226CrossRefPubMed Iwaki N, Fajgenbaum DC, Nabel CS, Gion Y, Kondo E, Kawano M et al (2016) Clinicopathologic analysis of TAFRO syndrome demonstrates a distinct subtype of HHV-8-negative multicentric Castleman disease. Am J Hematol 91(2):220–226CrossRefPubMed
13.
Zurück zum Zitat Kumar S, Sharma S (2015) Polyneuropathy, organomegaly, endocrinopathy, M-protein and skin changes (POEMS syndrome): a paraneoplastic syndrome. Oxf Med Case Rep 3:237–240CrossRef Kumar S, Sharma S (2015) Polyneuropathy, organomegaly, endocrinopathy, M-protein and skin changes (POEMS syndrome): a paraneoplastic syndrome. Oxf Med Case Rep 3:237–240CrossRef
14.
Zurück zum Zitat Carbone A, Pantanowitz L (2016) TAFRO syndrome: an atypical variant of KSHV-negative multicentric Castleman disease. Am J Hematol 91(2):171–172CrossRefPubMed Carbone A, Pantanowitz L (2016) TAFRO syndrome: an atypical variant of KSHV-negative multicentric Castleman disease. Am J Hematol 91(2):171–172CrossRefPubMed
15.
Zurück zum Zitat Masaki Y, Nakajima A, Iwao H, Kurose N, Sato T, Nakamura T et al (2013) Japanese variant of multicentric Castleman’s disease associated with serositis and thrombocytopenia—a report of two cases: is TAFRO syndrome (Castleman-Kojima disease) a distinct clinicopathological entity? J Clin Exp Hematop 53(1):79–85CrossRefPubMed Masaki Y, Nakajima A, Iwao H, Kurose N, Sato T, Nakamura T et al (2013) Japanese variant of multicentric Castleman’s disease associated with serositis and thrombocytopenia—a report of two cases: is TAFRO syndrome (Castleman-Kojima disease) a distinct clinicopathological entity? J Clin Exp Hematop 53(1):79–85CrossRefPubMed
16.
Zurück zum Zitat Kawashima M, Usui T, Okada H, Mori I, Yamauchi M, Ikeda T et al (2015) TAFRO syndrome: 2 cases and review of the literature. Mod Rheumatol 20:1–5 Kawashima M, Usui T, Okada H, Mori I, Yamauchi M, Ikeda T et al (2015) TAFRO syndrome: 2 cases and review of the literature. Mod Rheumatol 20:1–5
17.
Zurück zum Zitat Kojima M, Nakamura N, Otuski Y, Itoh H, Ogawa Y, Kobayashi H et al (2008) Pulmonary lesion of idiopathic plasmacytic lymphadenopathy with polyclonal hyperimmunoglobulinemia appears to be a cause of lymphoplasmacytic proliferation of the lung: a report of five cases. Pathol Res Pract 204(3):185–190CrossRefPubMed Kojima M, Nakamura N, Otuski Y, Itoh H, Ogawa Y, Kobayashi H et al (2008) Pulmonary lesion of idiopathic plasmacytic lymphadenopathy with polyclonal hyperimmunoglobulinemia appears to be a cause of lymphoplasmacytic proliferation of the lung: a report of five cases. Pathol Res Pract 204(3):185–190CrossRefPubMed
18.
Zurück zum Zitat Sakai K, Maeda T, Kuriyama A, Shimada N, Notohara K, Ueda Y (2016) TAFRO syndrome successfully treated with tocilizumab: a case report and systematic review. Mod Rheumatol 17:1–6CrossRef Sakai K, Maeda T, Kuriyama A, Shimada N, Notohara K, Ueda Y (2016) TAFRO syndrome successfully treated with tocilizumab: a case report and systematic review. Mod Rheumatol 17:1–6CrossRef
19.
Zurück zum Zitat Kourelis TV, Buadi FK, Kumar SK, Gertz MA, Lacy MQ, Dingli D et al (2016) Long-term outcome of patients with POEMS syndrome: an update of the Mayo Clinic experience. Am J Hematol 91(6):585–589CrossRefPubMed Kourelis TV, Buadi FK, Kumar SK, Gertz MA, Lacy MQ, Dingli D et al (2016) Long-term outcome of patients with POEMS syndrome: an update of the Mayo Clinic experience. Am J Hematol 91(6):585–589CrossRefPubMed
Metadaten
Titel
Neuro-ophthalmological findings in TAFRO syndrome in a patient from South America, a variant of multicentric Castleman’s disease
verfasst von
Alvaro Ortiz
Pedro Cárdenas
Marcela Peralta
Harold Rodríguez
Gabriel Frederick
Jacobo Ortiz
Publikationsdatum
27.07.2017
Verlag
Springer Netherlands
Erschienen in
International Ophthalmology / Ausgabe 4/2018
Print ISSN: 0165-5701
Elektronische ISSN: 1573-2630
DOI
https://doi.org/10.1007/s10792-017-0636-x

Weitere Artikel der Ausgabe 4/2018

International Ophthalmology 4/2018 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Ophthalmika in der Schwangerschaft

Die Verwendung von Ophthalmika in der Schwangerschaft und Stillzeit stellt immer eine Off-label-Anwendung dar. Ein Einsatz von Arzneimitteln muss daher besonders sorgfältig auf sein Risiko-Nutzen-Verhältnis bewertet werden. In der vorliegenden …

Operative Therapie und Keimnachweis bei endogener Endophthalmitis

Vitrektomie Originalie

Die endogene Endophthalmitis ist eine hämatogen fortgeleitete, bakterielle oder fungale Infektion, die über choroidale oder retinale Gefäße in den Augapfel eingeschwemmt wird [ 1 – 3 ]. Von dort infiltrieren die Keime in die Netzhaut, den …

Bakterielle endogene Endophthalmitis

Vitrektomie Leitthema

Eine endogene Endophthalmitis stellt einen ophthalmologischen Notfall dar, der umgehender Diagnostik und Therapie bedarf. Es sollte mit geeigneten Methoden, wie beispielsweise dem Freiburger Endophthalmitis-Set, ein Keimnachweis erfolgen. Bei der …

So erreichen Sie eine bestmögliche Wundheilung der Kornea

Die bestmögliche Wundheilung der Kornea, insbesondere ohne die Ausbildung von lichtstreuenden Narben, ist oberstes Gebot, um einer dauerhaften Schädigung der Hornhaut frühzeitig entgegenzuwirken und die Funktion des Auges zu erhalten.   

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.